SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-092858
Filing Date
2017-03-23
Accepted
2017-03-23 08:04:01
Documents
6
Period of Report
2017-05-02
Effectiveness Date
2017-03-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d330204ddef14a.htm DEF 14A 1374209
2 GRAPHIC g330204g10v55.jpg GRAPHIC 30818
3 GRAPHIC g330204g28e77.jpg GRAPHIC 7286
4 GRAPHIC g330204g29w56.jpg GRAPHIC 39442
5 GRAPHIC g330204g45x09.jpg GRAPHIC 12263
6 GRAPHIC g330204g69b62.jpg GRAPHIC 37433
  Complete submission text file 0001193125-17-092858.txt   1544166
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14956 | Film No.: 17708195
SIC: 2834 Pharmaceutical Preparations